Clinical insights into EchoGo® by Ultromics: experts from Mayo Clinic, The University of Chicago Medicine, and City of Hope share real-world experiences, implementation examples, and recent clinical study results.

This is an informational presentation brought to you by Ultromics. No credits are available.

• Learning Objectives:
  • Understand the scientific development and validation of EchoGo®, and how echo-based AI diagnostics are being applied for early detection of HFpEF and cardiac amyloidosis (Dr. Patricia Pellikka)
  • Review findings from the European Heart Journal study, showing how EchoGo® Amyloidosis can detect cardiac amyloidosis from a single A4C video clip, and its potential role in earlier diagnosis (Dr. Jeremy Slivnick)
  • Examine how EchoGo® is being integrated into real-world practice, including how AI results inform referral decisions and guide treatment pathways for patients with suspected HFpEF or cardiac amyloidosis (Dr. Faizi Jamal)
    

• Speaker List:
  • Patricia A. Pellikka, MD, FASE – Mayo Clinic
  • Jeremy A. Slivnick, MD, FASE – University of Chicago Medicine
  • Faizi A. Jamal, MD, FACC – City of Hope
  • Ross Upton, PhD – Founder & CEO, Ultromics

• Contact:
  ASE Learning Hub